Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 32, 2010 - Issue 5
42
Views
11
CrossRef citations to date
0
Altmetric
Articles

Common genetic coagulation variants are not associated with ischemic stroke in a case-control study

, , , , , , , & show all
Pages 519-522 | Published online: 19 Jul 2013

References

  • Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698–3703
  • Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64–67
  • Juul K, Tybjaerg-Hansen A, Schnohr P, et al. Factor V Leiden andthe risk for venous thromboembolism in the adult Danish population. Ann Intern Med 2004; 140: 330–337
  • Simioni P, Prandoni P, Lensing AW, et al. The risk of recurrentvenous thromboembolism in patients with an Arg506—>G1n mutation in the gene for factor V (factor V Leiden). N Engl J Med 1997; 336: 399–403
  • Ridker PM, Hennekens CH, Lindpaintner K, et al. Mutation in thegene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912–917
  • de Stefano V, Martinelli I, Mannucci PM, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 1999; 341: 801–806
  • Casas JP, Hingorani AD, Bautista LE, et al. Meta-analysis of genetic studies in ischemic stroke: Thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 2004; 61: 1652–1661
  • Kohler HP, Stickland MH, Ossei-Gerning N, et al. Association ofa common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8–13
  • Mikkola H, Syrjala M, Rasi V, et al. Deficiency in the A-subunit ofcoagulation factor XIII: Two novel point mutations demonstrate different effects on transcript levels. Blood 1994; 84: 517–525
  • Elbaz A, Poirier O, Canaple S, et al. The association between the Va134Leu polymorphism in the factor XIII gene and brain infarction. Blood 2000; 95: 586–591
  • Franco RF, Reitsma PH, Lourenco D, et al. Factor XIII Va134Leu is a genetic factor involved in the etiology of venous thrombosis. Thromb Haemost 1999; 81: 676–679
  • Catto AJ, Kohler HP, Bannan S, et al. Factor XIII Val 34 Leu: A novel association with primary intracerebral hemorrhage. Stroke 1998; 29: 813–816
  • Aleksic N, Ahn C, Wang YVV, et al. Factor XIIIA Va134Leu polymorphism does not predict risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vase Biol 2002; 22: 348–352
  • Canavy I, Henry M, Morange PE, et al. Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost 2000; 83: 212–216
  • Corral J, Gonzalez-Conejero R, Iniesta JA, et al. The FXIII Va134Leu polymorphism in venous and arterial thromboembolism. Haematologica 2000; 85: 293–297
  • Corral J, Iniesta JA, Gonzalez-Conejero R, et al. Factor XIII Va134Leu polymorphism in primary intracerebral haemorrhage. Hematol J 2000; 1: 269–273
  • Endler G, Funk M, Haering D, et al. Is the factor XIII 34Va1/Leu polymorphism a protective factor for cerebrovascular disease? Br J Haematol 2003; 120: 310–314
  • Adams HP, Jr, Bendixen BH, Kappelle Li, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35–41
  • Happich D, Schwaab R, Hanfland P, et at Allelic discrimination of factor V Leiden using a 5' nuclease assay. Thromb Haemost 1999; 82: 1294–1296
  • Happich D, Madlener K, Schwaab R, et al. Application of the TaqMan-PCR for genotyping of the prothrombin G20210A mutation and of the thermolabile methylenetetrahydrofolate reductase mutation. Thromb Haemost 2000; 84: 144–145
  • Kraus JA, Stuper BK, Muller J, et al. Molecular analysis of thrombophilic risk factors in patients with dural arteriovenous fistulas. J Neurol 2002; 249: 680–682
  • Eterovic D, Titlic M, Culic V, et al. Lower contribution of factor VLeiden or G202104 mutations to ischemic stroke in patients with clinical risk factors: Pair-matched case-control study. Clin Appl Thromb Hemost 2007; 13: 188–193
  • Berge E, Haug KB, Sandset EC, et at The factor V Leiden, prothrombingene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein Ma 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation. Stroke 2007; 38: 1069–1071
  • Lichy C, Reuner KH, Buggle F, et al. Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia. Cerebrovasc Dis 2003; 16: 83–87
  • Karttunen V, Hiltunen L, Rasi V, et al. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis 2003; 14: 261–268
  • Botto N, Spadoni I, Giusti S, et al. Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke 2007; 38: 2070–2073.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.